Super Shred
- Fat loss & metabolism
- Recovery & repair
An injectable blend of L-carnitine, a methionine/inositol/choline lipotropic mix, ATP and vitamin B12 that also contains albuterol, a prescription beta-2 agonist bronchodilator.
Read the published research →What Super Shred does
Nothing has been published on this mixture, so what is known comes from its constituents studied separately, and mostly by mouth or by inhaler rather than by injection. Pooled randomized trials of oral L-carnitine show roughly 1.2 to 1.3 kg more weight loss than control, at a modelled peak dose about five times the carnitine in one vial. Choline's clearest human result is corrective rather than cosmetic: choline chloride added to parenteral feed, at roughly twenty times the vial's whole MIC blend, reversed liver fat and lowered ALT and AST in choline-deprived patients. Oral ATP improved maximal strength over placebo in resistance-trained men, again at about eight times the ATP here. Albuterol carries both the strongest body-composition signal and the clearest harm, and they come from the same men: in the 11-week trial that found 1.8 kg more lean mass than placebo, the dose was eight times this vial's albuterol and swallowed, and wall thickness rose on echocardiography, muscle oxidative enzyme activity fell, and endurance failed to improve where placebo gained 7%.
- fat metabolism and body composition
- lipotropic support for hepatic fat handling
- maximal strength during resistance training
- post-exercise muscle protein balance
- correcting vitamin B12 status
- beta-2 adrenergic stimulation
Common areas of interest, not measured results. The findings below are the published data.
Thirty trained men took oral salbutamol 16 mg per day or placebo across 11 weeks of supervised full-body resistance training. Lean mass rose 1.8 kg more than placebo (95% CI 0.5 to 3.1), while echocardiographic posterior, septal and relative wall thickness increased, muscle citrate synthase and 3-HAD activity fell, and time to exhaustion did not improve where placebo gained 7%. That daily oral dose is eight times this vial's albuterol.10
Nineteen female and 21 male well-trained adults inhaled 800-1600 ug salbutamol per training day across six weeks of endurance and interval training. Fat mass fell 0.8 kg versus placebo in females only (95% CI -0.5 to -1.6; sex-by-treatment p = 0.048), with no fat loss in males. Maximal oxygen uptake gains were blunted in both sexes, and quadriceps strength fell 39 N/m versus placebo in females.11
Fifteen patients dependent on long-term home parenteral nutrition were randomized to 2 g choline chloride added to their parenteral feed or usual feed for 24 weeks. Liver attenuation on CT rose 13.3 versus 5.8 Hounsfield units at four weeks and serum ALT and AST fell versus placebo; steatosis recurred 10 weeks after choline stopped. That daily amount is roughly twenty times the vial's whole 100 mg MIC blend.5
For laboratory research use only. Not a drug, food, or cosmetic. Not for human or veterinary use, ingestion, or any form of consumption. Sold exclusively to qualified researchers.
